De-escalation of biological therapy in Inflammatory Bowel Disease patients following prior escalation

被引：0
|
作者：
Thomas, P. [1 ]
Smits, L. [1 ]
Groen, M. Te [1 ]
West, R. [2 ]
Russel, M. [3 ]
Jansen, J. [4 ]
Romkens, T. [5 ]
Hoentjen, F. [1 ]
机构：
[1] Radboudumc, Gastroenterol & Hepatol, Nijmegen, Netherlands
[2] Franciscus Gasthuis & Vlietland, Gastroenterol & Hepatol, Rotterdam, Netherlands
[3] Medisch Spectrum Twente, Gastroenterol & Hepatol, Enschede, Netherlands
[4] Onze Lieve Vrouw Hosp, Gastroenterol & Hepatol, Amsterdam, Netherlands
[5] Jeroen Bosch Ziekenhuis, Gastroenterol & Hepatol, Shertogenbosch, Netherlands
来源：
JOURNAL OF CROHNS & COLITIS | 2021年 / 15卷
关键词：
D O I：
10.1093/ecco-jcc/jjab073.090
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
DOP51
引用
收藏
页码：S086 / S086
页数：1
相关论文
共 50 条
  • [1] De-escalation of biological therapy in inflammatory bowel disease patients following prior dose escalation
    Thomas, Pepijn W. A.
    Smits, Lisa J. T.
    Te Groen, Maarten
    West, Rachel L.
    Russel, Maurice G. V. M.
    Jansen, Jeroen M.
    Romkens, Tessa E. H.
    Hoentjen, Frank
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 34 (05) : 488 - 495
  • [2] De-escalation of immunomodulator and biological therapy in inflammatory bowel disease
    Chapman, Thomas P.
    Gomes, Catarina Frias
    Louis, Edouard
    Colombel, Jean-Frederic
    Satsangi, Jack
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2020, 5 (01): : 63 - 79
  • [3] De-escalation of Therapy in Inflammatory Bowel Disease
    Frias Gomes C.
    Colombel J.-F.
    Torres J.
    [J]. Current Gastroenterology Reports, 2018, 20 (8)
  • [4] De-escalation of Therapy in Patients with Quiescent Inflammatory Bowel Disease
    Miyatani, Yusuke
    Kobayashi, Taku
    [J]. GUT AND LIVER, 2023, 17 (02) : 181 - 189
  • [5] De-escalation of biological therapy in inflammatory bowel disease: Benefits and risks
    Fredericks, E.
    Watermeyer, G.
    [J]. SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2019, 109 (10): : 745 - 749
  • [6] De-escalation of medical therapy in inflammatory bowel disease
    Gomes, Catarina Frias
    Chapman, Thomas P.
    Satsangi, Jack
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2020, 55 : 73 - 81
  • [7] De-escalation of Combination Drug Therapy in Inflammatory Bowel Disease Patients
    Saleh, Adam A.
    Waghela, Rajdeepsingh
    Garza, Manuel
    Stading, Rachel
    Miroballi, Natalia
    Moskow, Joshua
    Thurston, Theresa
    Abraham, Bincy
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S722 - S722
  • [8] Inflammatory bowel disease in the clinic: Escalation and de-escalation of therapy: A longitudinal case-based discussion
    Begun, Jakob
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 12 - 13
  • [9] Evaluation of de-escalation of anti-TNF-α therapy in inflammatory bowel disease
    Sedano Munoz, Rocio
    Quera Pino, Rodrigo
    Lubascher Correa, Jaime
    Pizarro Jofre, Gonzalo
    Simian Marin, Daniela
    [J]. GASTROENTEROLOGIA Y HEPATOLOGIA, 2019, 42 (02): : 133 - 140
  • [10] Treatment de-escalation in inflammatory bowel diseases
    Abitbol, Vered
    [J]. PRESSE MEDICALE, 2018, 47 (11-12): : 931 - 933
12345